When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HGEN - Humanigen secures new U.S. patent for lenzilumab
Humanigen Inc.
The USPTO has issued a patent to Humanigen (HGEN) for the use of lenzilumab in prevention or treatment of cytokine storm, neurotoxicity in patients undergoing chimeric antigen receptor T (CAR-T) cell therapy and inhibit or reduce incidence or severity of CAR-T-related toxicities. The patent, titled “Methods of Treating Immunotherapy-Related Toxicity Using a GM-CSF Antagonist,” was issued on December 22, 2020 as U.S. Patent No. 10,870,703.Shares up 2% premarket.